Three independent discounted-cash-flow-style models value AbbVie Inc. every trading day. 0 of 3 currently price ABBV above its market price.
| Free Cash Flow model | $251.28 |
| Excess Profit model | $70.19 |
| Residual Earnings model | $-1.94 |
| Dividend Discount model | $279.63 |
| Piotroski F-Score | 8 / 9 |
| Return on invested capital | +24.7% |
| Net debt / EBITDA | 2.2× |
| Gross margin | +70.2% |
| Revenue CAGR | +1.8% |
| Cash conversion | 4.5× |
| Dividend yield | +2.6% |
| Buyback yield | -0.1% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open ABBV in StockKitty